Adoption of the New CLSI Fluoroquinolone Breakpoints for Enterobacteriaceae

Lignende værker

• Reply to Chu et al., “Adoption of the New CLSI Fluoroquinolone Breakpoints for Enterobacteriaceae”
  af: Van, Tam T., et al.
  Udgivet: (2019)
• 2184. Effect of Adjusted CLSI Breakpoints on Center-wide Fluoroquinolone Susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is It Time to Restrict Empiric Fluoroquinolone Use?
  af: Sansom, Sarah, et al.
  Udgivet: (2019)
• 1599. Clinical Outcomes for Patients Treated with Fluoroquinolones for Bacteremia Caused by Enterobacteriaceae Reclassified as Not Susceptible by Updated CLSI Breakpoints
  af: Fleischner, Zachary, et al.
  Udgivet: (2020)
• 1549. Impact of New Fluoroquinolone Breakpoints on Enterobacteriaceae Susceptibility Rates and Clinical Outcomes
  af: Pettit, Natasha N, et al.
  Udgivet: (2019)
• Susceptibility of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae According to the New CLSI Breakpoints
  af: Wang, Peng, et al.
  Udgivet: (2011)